發送短信

數:

提供者:

CAPTCHA:

  _____     ______             __   __    ______  
 |__  //   /_   _//     ___    \ \\/ //  /_   _// 
   / //     -| ||-     /   ||   \ ` //   `-| |,-  
  / //__    _| ||_    | [] ||    | ||      | ||   
 /_____||  /_____//    \__ ||    |_||      |_||   
 `-----`   `-----`      -|_||    `-`'      `-`'   
                         `-`

Please enter what you see:

發送短信 : A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22